28081533|t|EEG Monitoring Technique Influences the Management of Hypoxic-Ischemic Seizures in Neonates Undergoing Therapeutic Hypothermia
28081533|a|Electroencephalogram (EEG) monitoring techniques for neonatal hypoxia-ischemia (HI) are evolving over time, and the specific type of EEG utilized could influence seizure diagnosis and management. We examined whether the type of EEG performed affected seizure treatment decisions (e.g., the choice and number of antiseizure drugs [ASDs]) in therapeutic hypothermia-treated neonates with HI from 2007 to 2015 in the Johns Hopkins Hospital Neonatal Intensive Care Unit. During this period, 3 different EEG monitoring protocols were utilized: Period 1 (2007-2009), single, brief conventional EEG (1 h duration) at a variable time during therapeutic hypothermia treatment, i.e., ordered when a seizure was suspected; Period 2 (2009-2013), single, brief conventional EEG followed by amplitude-integrated EEG for the duration of therapeutic hypothermia treatment and another brief conventional EEG after rewarming; and Period 3 (2014-2015), continuous video-EEG (cEEG) for the duration of therapeutic hypothermia treatment (72 h) plus for an additional 12 h during and after rewarming. One hundred and sixty-two newborns were included in this retrospective cohort study. As a function of the type and duration of EEG monitoring, we assessed the risk (likelihood) of receiving no ASD, at least 1 ASD, or ≥2 ASDs. We found that the risk of a neonate being prescribed an ASD was 46% less during Period 3 (cEEG) than during Period 1 (brief conventional EEG only) (95% CI 6-69%, p = 0.03). After adjusting for initial EEG and MRI results, compared with Period 1, there was a 38% lower risk of receiving an ASD during Period 2 (95% CI: 9-58%, p = 0.02) and a 67% lower risk during Period 3 (95% CI: 23-86%, p = 0.01). The risk ratio of receiving ≥2 ASDs was not significantly different across the 3 periods. In conclusion, in addition to the higher sensitivity and specificity of continuous video-EEG monitoring, fewer infants are prescribed an ASD when undergoing continuous forms of EEG monitoring (aEEG or cEEG) than those receiving conventional EEG. We recommend that use of continuous video-EEG be considered whenever possible, both to treat seizures more specifically and to avoid overtreatment.
28081533	0	3	EEG	T060	C0013819
28081533	4	14	Monitoring	T058	C1283169
28081533	15	24	Technique	T169	C0449851
28081533	25	35	Influences	T077	C4054723
28081533	40	50	Management	T058	C0376636
28081533	54	79	Hypoxic-Ischemic Seizures	T047	C0752304
28081533	83	91	Neonates	T100	C0021289
28081533	103	126	Therapeutic Hypothermia	T061	C0020674
28081533	127	147	Electroencephalogram	T034	C1527380
28081533	149	152	EEG	T034	C1527380
28081533	154	164	monitoring	T058	C1283169
28081533	165	175	techniques	T169	C0449851
28081533	180	188	neonatal	T100	C0021289
28081533	189	205	hypoxia-ischemia	T047	C0752308
28081533	207	209	HI	T047	C0752308
28081533	215	223	evolving	T169	C0332253
28081533	260	263	EEG	T034	C1527380
28081533	279	288	influence	T077	C4054723
28081533	289	296	seizure	T184	C0036572
28081533	297	306	diagnosis	T033	C0011900
28081533	311	321	management	T058	C0376636
28081533	355	358	EEG	T060	C0013819
28081533	378	385	seizure	T184	C0036572
28081533	386	405	treatment decisions	T033	C4061230
28081533	438	455	antiseizure drugs	T121	C1254351
28081533	457	461	ASDs	T121	C1254351
28081533	467	478	therapeutic	T169	C0302350
28081533	479	498	hypothermia-treated	T061	C0150255
28081533	499	507	neonates	T100	C0021289
28081533	513	515	HI	T047	C0752308
28081533	541	592	Johns Hopkins Hospital Neonatal Intensive Care Unit	T073,T093	C0021709
28081533	606	612	period	T079	C1948053
28081533	626	629	EEG	T034	C1527380
28081533	630	640	monitoring	T058	C1283169
28081533	641	650	protocols	T061	C0008971
28081533	666	674	Period 1	T079	C1948053
28081533	696	714	brief conventional	T169	C0205245
28081533	715	718	EEG	T060	C0013819
28081533	724	732	duration	T079	C0449238
28081533	739	752	variable time	T079	C0040223
28081533	760	771	therapeutic	T169	C0302350
28081533	772	793	hypothermia treatment	T061	C0150255
28081533	816	823	seizure	T184	C0036572
28081533	828	837	suspected	T047	C0277540
28081533	839	847	Period 2	T079	C1948053
28081533	869	887	brief conventional	T169	C0205245
28081533	888	891	EEG	T060	C0013819
28081533	904	928	amplitude-integrated EEG	T060	C0013819
28081533	937	945	duration	T079	C0449238
28081533	949	960	therapeutic	T169	C0302350
28081533	961	982	hypothermia treatment	T061	C0150255
28081533	995	1013	brief conventional	T169	C0205245
28081533	1014	1017	EEG	T060	C0013819
28081533	1024	1033	rewarming	T061	C0206156
28081533	1039	1047	Period 3	T079	C1948053
28081533	1061	1081	continuous video-EEG	T060	C0430800
28081533	1083	1087	cEEG	T060	C0430800
28081533	1097	1105	duration	T079	C0449238
28081533	1109	1120	therapeutic	T169	C0302350
28081533	1121	1142	hypothermia treatment	T061	C0150255
28081533	1195	1204	rewarming	T061	C0206156
28081533	1232	1240	newborns	T100	C0021289
28081533	1263	1289	retrospective cohort study	T062	C2985505
28081533	1321	1329	duration	T079	C0449238
28081533	1333	1336	EEG	T034	C1527380
28081533	1337	1347	monitoring	T058	C1283169
28081533	1352	1360	assessed	T052	C1516048
28081533	1365	1369	risk	T078	C0035647
28081533	1371	1381	likelihood	T081	C0033204
28081533	1399	1402	ASD	T121	C1254351
28081533	1415	1418	ASD	T121	C1254351
28081533	1426	1430	ASDs	T121	C1254351
28081533	1450	1454	risk	T078	C0035647
28081533	1460	1467	neonate	T100	C0021289
28081533	1488	1491	ASD	T121	C1254351
28081533	1512	1520	Period 3	T079	C1948053
28081533	1522	1526	cEEG	T060	C0430800
28081533	1540	1548	Period 1	T079	C1948053
28081533	1550	1568	brief conventional	T169	C0205245
28081533	1569	1572	EEG	T060	C0013819
28081533	1633	1636	EEG	T060	C0013819
28081533	1641	1644	MRI	T060	C0024485
28081533	1645	1652	results	T169	C1274040
28081533	1668	1676	Period 1	T079	C1948053
28081533	1700	1704	risk	T078	C0035647
28081533	1721	1724	ASD	T121	C1254351
28081533	1732	1740	Period 2	T079	C1948053
28081533	1783	1787	risk	T078	C0035647
28081533	1795	1803	Period 3	T079	C1948053
28081533	1836	1846	risk ratio	T081	C0028873
28081533	1863	1867	ASDs	T121	C1254351
28081533	1913	1920	periods	T079	C1948053
28081533	1963	1974	sensitivity	T081	C1511883
28081533	1979	1990	specificity	T081	C1511884
28081533	1994	2014	continuous video-EEG	T060	C0430800
28081533	2015	2025	monitoring	T058	C1283169
28081533	2033	2040	infants	T100	C0021270
28081533	2059	2062	ASD	T121	C1254351
28081533	2099	2102	EEG	T034	C1527380
28081533	2103	2113	monitoring	T058	C1283169
28081533	2115	2119	aEEG	T060	C0013819
28081533	2123	2127	cEEG	T060	C0430800
28081533	2150	2162	conventional	T169	C0205245
28081533	2163	2166	EEG	T060	C0013819
28081533	2193	2213	continuous video-EEG	T060	C0430800
28081533	2261	2269	seizures	T184	C0036572
28081533	2301	2314	overtreatment	T058	C4046039